Why Pfizer’s 4% Yield Is Your Best Covid-19 Vaccine Play

Written by Robert Kovacs
Back in May, I wrote an article in which I suggested that with or without a Covid-19 vaccine, Pfizer (PFE) was a buy.
Since then the stock has dropped 15% and climbed back to the price it was a quarter ago. Pfizer is currently trading at $37.79 and yields 4.02%.
Source: Open Domain
Quite a lot can happen in 3 months. And quite a lot has happened. For one, Mylan (MYL) shareholders overwhelmingly approved the Upjohn-Mylan merger which is expected to close…

Click here to view the original article.